Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

NCT03136484 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

788

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide
DRUG: Canagliflozin
DRUG: Placebo (canagliflozin)
DRUG: Placebo (semaglutide)

Sponsor

Novo Nordisk A/S